John Ketcham
AeroLeads people directory · profile

John Ketcham Email & Phone Number

Senior Director, Medicinal Chemistry at Ten63 Therapeutics
Location: Raleigh-Durham-Chapel Hill Area, United States 10 work roles 2 schools
1 work email found @mirati.com LinkedIn matched
✓ Verified July 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email k****@mirati.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Senior Director, Medicinal Chemistry
Location
Raleigh-Durham-Chapel Hill Area, United States

Who is John Ketcham? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

John Ketcham is listed as Senior Director, Medicinal Chemistry at Ten63 Therapeutics, based in Raleigh-Durham-Chapel Hill Area, United States. AeroLeads shows a work email signal at mirati.com and a matched LinkedIn profile for John Ketcham.

John Ketcham previously worked as Director, Medicinal Chemistry at Mirati Therapeutics – A Bristol Myers Squibb company. at Bristol Myers Squibb and Director - Drug Discovery, Medicinal Chemistry at Mirati Therapeutics. John Ketcham holds Doctor Of Philosophy (Ph.D.), Chemistry - Synthetic Organic from University Of Florida.

Company email context

Email format at Ten63 Therapeutics

This section adds company-level context without repeating John Ketcham's masked contact details.

{last}{first_initial}@mirati.com
86% confidence

AeroLeads found 1 current-domain work email signal for John Ketcham. Compare company email patterns before reaching out.

Profile bio

About John Ketcham

Harnessing complex organic synthesis and molecular modeling to develop and enhance the SAR of various scaffolds, with the eventual goal of developing clinical candidates for use in Immunoncology (IO) and Targeted Oncology. Working closely with medicinal chemists, discovery biologists, quantitative biologists, pharmacologists, and DMPK scientists to achieve these goals.

Listed skills include Chemistry, Catalysis, Organic Synthesis, Organic Chemistry, and 16 others.

Current workplace

John Ketcham's current company

Company context helps verify the profile and gives searchers a useful next step.

Ten63 Therapeutics
Ten63 Therapeutics
Senior Director, Medicinal Chemistry
AeroLeads page
10 roles · 21 years

John Ketcham work experience

A career timeline built from the work history available for this profile.

Senior Director, Medicinal Chemistry

Current

Durham, North Carolina, Us

May 2024 - Present

Director, Medicinal Chemistry At Mirati Therapeutics – A Bristol Myers Squibb Company.

Lawrence Township, Nj, Us

Jan 2024 - May 2024

Director - Drug Discovery, Medicinal Chemistry

San Diego, California, Us

https://www.mirati.com/pipeline/

2022 - Jan 2024

Associate Director - Drug Discovery, Medicinal Chemistry

San Diego, California, Us

2020 - 2022 ~2 yrs

Principal Scientist - Drug Discovery, Medicinal Chemistry

San Diego, California, Us

Dec 2018 - 2020

Scientist Ii - Medicinal Chemistry

Flx Bio, Inc. (Now Rapt Therapeutics)
2017 - Nov 2018

Scientist I - Medicinal Chemistry

Flx Bio, Inc. (Now Rapt Therapeutics)
2015 - 2017 ~2 yrs

Postdoctoral Fellow, Advisor: Professor Michael J. Krische

Austin, Tx, Us

Applying C-C bond forming transfer hydrogenations in the total syntheses of biologically relevant natural products, under the direction of Professor Michael J. Krische. More specifically, our goal is to design simplified functional analogues of Bryostatin and evaluate their effects in biological systems.

2013 - 2015 ~2 yrs

Ph. D. In Chemistry, Advisor: Professor Aaron Aponick

Gainesville, Florida, Us

Development of new synthetic methodology using homogenous gold and ruthenium catalysis. Synthesis of a variety of functionalized substrates to test the scope and limitations of these methods, including their applications in natural product syntheses.

2007 - 2013 ~6 yrs

Research Assistant; Advisors: Professors Seth Elsheimer And Clovis Linkous

Orlando, Fl, Us

Toward the Synthesis of a Superacid-substituted PEEK monomer for use in Proton Exchange Membranes (PEMs):Applying air-free chemical techniques toward the synthesis of a superacid-substituted monomer for future implementation into Proton Exchange Membranes (PEMs).Research Assistant with Dr. Clovis A. Linkous, Florida Solar Energy Center and Dr. Seth Elsheimer, University of Central Florida

2006 - 2007 ~1 yr
2 education records

John Ketcham education

Doctor Of Philosophy (Ph.D.), Chemistry - Synthetic Organic

University Of Florida

Bachelor Of Science (B.S.), Chemistry

University Of Central Florida
FAQ

Frequently asked questions about John Ketcham

Quick answers generated from the profile data available on this page.

What company does John Ketcham work for?

John Ketcham works for Ten63 Therapeutics.

What is John Ketcham's role at Ten63 Therapeutics?

John Ketcham is listed as Senior Director, Medicinal Chemistry at Ten63 Therapeutics.

What is John Ketcham's email address?

AeroLeads has found 1 work email signal at @mirati.com for John Ketcham at Ten63 Therapeutics.

Where is John Ketcham based?

John Ketcham is based in Raleigh-Durham-Chapel Hill Area, United States while working with Ten63 Therapeutics.

What companies has John Ketcham worked for?

John Ketcham has worked for Ten63 Therapeutics, Bristol Myers Squibb, Mirati Therapeutics, Flx Bio, Inc. (Now Rapt Therapeutics), and The University Of Texas At Austin.

How can I contact John Ketcham?

You can use AeroLeads to view verified contact signals for John Ketcham at Ten63 Therapeutics, including work email, phone, and LinkedIn data when available.

What schools did John Ketcham attend?

John Ketcham holds Doctor Of Philosophy (Ph.D.), Chemistry - Synthetic Organic from University Of Florida.

What skills is John Ketcham known for?

John Ketcham is listed with skills including Chemistry, Catalysis, Organic Synthesis, Organic Chemistry, Nmr, Spectroscopy, Mass Spectrometry, and Hplc.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.